Chris Beauchamp, chief market analyst at investing platform IG, has named Tesco, Alphabet and AstraZeneca as his top three stocks for active investors going into 2027.
On Tesco, Beauchamp said its decision to increase share buybacks alongside capital expenditure reflects management's confidence in the outlook and the strength of its cash generation. He believes the supermarket group offers a combination of defensive qualities, reliable earnings and shareholder returns.
Alphabet has shown it can adapt to AI rather than become a casualty of it, Beauchamp said, integrating the technology into search while continuing to grow advertising revenues. He noted that shares in Alphabet fell 12.6% on 29 October following a results announcement that showed a slowdown in its Search revenue. Beauchamp said Google Cloud provides another engine for growth, and described the company's cash generation, profits and balance sheet as giving it the financial firepower to keep investing.
Beauchamp said AstraZeneca stands out for the strength and breadth of its medicines portfolio, its pipeline of potential new treatments and its track record of delivering growth. He said its $2 billion investment in Summit Therapeutics demonstrates a disciplined approach to innovation, gaining exposure to a promising new cancer treatment through a minority stake and clinical collaboration without taking on the full financial risk.
Beauchamp identified four themes for investors: AI, oil prices, inflation and earnings. He said investors are torn between hopes that AI will deliver huge earnings growth and worries that capital expenditure levels will be excessive. Brent crude continues to hover above $90 a barrel amid the US's ongoing war with Iran, which has led to attacks on Saudi Arabia and hamstrung shipping through the Strait of Hormuz, he said. Elevated oil prices have fed through into increased costs and higher inflation readings, Beauchamp added, tipping central banks back into tightening efforts.